a 63162 has been researched along with hydroxyurea in 2 studies
| Studies (a 63162) | Trials (a 63162) | Recent Studies (post-2010) (a 63162) | Studies (hydroxyurea) | Trials (hydroxyurea) | Recent Studies (post-2010) (hydroxyurea) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 8,969 | 741 | 2,156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailie, MB; Carter, GW; Dahm, LJ; Harris, RR; Peters-Golden, M; Roth, RA | 1 |
| Funk, CD; Nair, DG | 1 |
2 other study(ies) available for a 63162 and hydroxyurea
| Article | Year |
|---|---|
Leukotrienes and alpha-naphthylisothiocyanate-induced liver injury.
Topics: 1-Naphthylisothiocyanate; Acetamides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcimycin; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Glutathione; Hydroxyurea; Indoles; Inflammation; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Liver; Liver Diseases; Male; Phenyl Ethers; Rats; Rats, Sprague-Dawley | 1995 |
A cell-based assay for screening lipoxygenase inhibitors.
Topics: Acetamides; Cell Line; Drug Evaluation, Preclinical; Fluorenes; Humans; Hydroxyurea; Inhibitory Concentration 50; Lipoxygenase; Lipoxygenase Inhibitors; Masoprocol; Microscopy, Fluorescence; Phenyl Ethers | 2009 |